Based on our results presented so far, we predicted that breast cancer cells with constitutive MAPK hyperactivation would exhibit a more pronounced sensitivity to E2-stimulated, ERα-mediated transcriptional activity upon FASN blockade. This evidence concerns the gene ESR1 and breast cancer.